A study of 11C-PBR28 and 18F-flortaucipir in patients with the non-fluent/agrammatic variant of primary progressive aphasia (nfvPPA) and/or apraxia of speech (AOS).
Latest Information Update: 09 Sep 2021
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Radiopharmaceuticals
- Indications Primary progressive aphasia
- Focus Diagnostic use
- 09 Sep 2021 New trial record
- 30 Jul 2021 Results presented at the Alzheimer's Association International Conference 2021